Page 15 - Read Online
P. 15

Buncke. Plast Aesthet Res 2022;9:38  https://dx.doi.org/10.20517/2347-9264.2022.08  Page 9 of 17


 Table 3. Clinical studies using off-the-shelf commercially available engineered nerve allografts reporting outcomes

 Implants
 Mean gap   Nerve type,   Mean follow-
 Author, year  Study type  used/n-  Outcomes
 length  n-value  up
 value
 Karabekmez et   Retrospective  22.3 mm   Sensory, n =   9 months  Allograft, n =   The average static two-point discrimination was 5.5 mm, and the moving two-point discrimination was 4.4
 [61]
 al.  , 2009  (Range 5-30   10  10  mm. This was the first study to show clinical efficacy for using clinically available engineered nerve grafts to
 mm)  treat sensory defects up to 3 cm in length
 [62]
 Brooks et al.  ,  Retrospective   22  11 mm   Sensory, n =   264  152 days  Allograft, n =   A meaningful recovery in 87.3% of repairs for motor (> M3) and sensory (> S3) function on MRCC scale.
 2012  observational  (Range 5-50   49   76  Provides functional recovery in sensory, mixed and motor nerve injuries in gaps up to 50 mm
 mm)  Mixed, n = 18
 Motor, n = 9
 [63]
 Cho et al.  ,   Retrospective   23  12 mm   Sensory, n =   296  160 days  Allograft, n =   Meaningful recovery (≥ S3 and ≥ M3)
 2012  observational  (Range 5-50   35   51  was achieved in 86% of cases
 mm)  Mixed, n = 13
 Motor, n = 3
 [47]
 Ducic et al.  ,   Retrospective   Primary, 0   Unknown  Primary 204.0  Primary, n = 8  The recorded average QuickDASH (disabilities of the arm, shoulder, and hand) questionnaire was reported to
 2012  observational  mm   41.3 weeks   Conduit, n = 27  average 23.2  19.8. There were no significant differences between repair type with respect to outcomes
 Conduit, 9.1   Conduit 186.4  Autograft, n =
 3.7 mm   56.7 weeks   11
 Autograft,   Autograft   Allograft, n = 8
 37.5  13.2 mm   250.5  59.3
 Allograft, 17.6   weeks
 7.5 mm  Allograft 129.7
 89.2 weeks
 [64]
 Guo et al.  ,   Retrospective   23 mm   Digital, n = 5  13 mon.   Allograft, n = 5 All patients reported sensory improvement during the follow-up period after operation. Mean Static two-point
 2013  observational  (Range 18-28   (Range 12-15   discrimination of 6 mm was recorded, and the range of the Semmes-Weinstein Monofilament test was 4.31 to
 mm)  months)  4.56
 [65]                [66]
 Taras et al.  ,   Prospective  11 mm   Digital, n = 18 15 mon.   Allograft, n =   According to custom Taras   scale, excellent results in 39% of repairs, good results in 44% of repairs, fair
 2013  (Range 5-30   (Range 12-20   18  results in 17% of repairs and poor results in no repairs
 mm)  months)
 Isaacs and   Retrospective   33  10 mm   Sensory, n = 2  13 months  Allograft, n =15 Meaningful recovery for motor (≥ M3) function in 85% of repairs and sensory (≥ S3) function in 67% of
 [67]
 Safa  , 2017  observational  (Range 5-50   Mixed, n = 13  repairs, independent of nerve diameter
 mm)
 [68]
 Rinker et al.  ,   Retrospective   35  8 mm    Sensory, n =   11 months  Allograft, n =   Meaningful recovery for sensory (≥ S3) function in 86% of repairs
 2017  observational  (Range 25-50  50  50
 mm)
 [69]
 Zhu et al.  ,   Retrospective   27 ± 13 mm  Sensory, n =   355  158 days  Allograft, n =   Meaningful recovery for motor (≥ M3) function in 66.7% of repairs and sensory (≥ S3) function in 84.6% of
 2017  observational  39   64  repairs
 Mixed, n = 19
 Motor, n = 6
 Carlson et al.  Retrospective   65  45 mm   Sensory, n =   15  5 months  Allograft, n =   Meaningful recovery for motor (≥ M3) function in 33.3% of repairs and sensory (≥ S3) in 91.7% of repairs
 [70]
 , 2018   observational  (Range 10-  11   19
    140 mm)  Mixed, n = 3
    Motor, n = 2
   10   11   12   13   14   15   16   17   18   19   20